Several inflammatory mediators, including interleukins (IL-6, IL-8, IL-10), tumor necrosis factor (TNF), and chemokines (CXCL12, CXCR4), are implicated in tumor progression and the pathological inflammatory microenvironment of these tumors (68). This evidence concerns the gene CXCL8 and neoplasm.